@lydiaaulozzi_'s peptide stack claims, fact-checked

What did @lydiaaulozzi_ actually say?

Honestly, not much we can work with. The transcript captured is "Sorry, I cannot hear you I'm kinda busy I could kinda be" — which appears to be audio interference or a cropped clip rather than any substantive health claim. The video hashtags tell a clearer story: #semax, #ss31, and #peptidestack suggest the creator is promoting or discussing a combination of these two compounds, likely pointing viewers toward a vendor via their Linktree bio.

We cannot fact-check claims that were not captured in the audio. What we can do is examine what is commonly claimed about this specific stack in peptide communities, since that context is clearly the intent of the post. The "vendor in bio" caption is its own red flag worth addressing directly.

Does the science back up common Semax and SS-31 claims?

Semax has real, peer-reviewed research behind it, mostly from Russian institutions. SS-31 has compelling preclinical data. Neither has cleared FDA approval for the uses peptide influencers typically promote.

Semax is a synthetic analogue of ACTH(4-7) with documented neuroprotective properties in animal and limited human studies. Kolomin et al. (2013, Journal of Molecular Neuroscience) showed it modulates BDNF expression in rat models. Russian clinical trials have explored it for stroke and cognitive impairment, but these studies are small, often not placebo-controlled by Western standards, and not replicated in large Western trials.

SS-31 (elamipretide) is a mitochondria-targeted peptide with more serious research pedigree. Szeto (2014, Phytomedicine) outlined its mechanism protecting cardiolipin in the inner mitochondrial membrane. Mitochondrial disease applications have reached Phase II trials. However, the leap from mitochondrial disease research to general "optimization" or anti-aging stacks is not supported by current evidence.

What did they get wrong, or right?

We cannot directly assess the creator's specific statements given the incomplete transcript. But the framing of the post deserves scrutiny. Directing an audience of over 11,000 viewers to an unverified peptide vendor, without any visible safety context, is a pattern that research-literate people should notice.

The hashtag #peptidestack implies combining compounds without any acknowledgment that drug interactions, purity standards, and individual health conditions matter enormously here. Research peptides sold by vendors are not pharmaceutical-grade medications. They are not subject to FDA manufacturing oversight. A 2021 analysis published in JAMA (Cohen et al.) found that many compounds sold in this market contain incorrect concentrations or contaminants.

If the creator is simply sharing personal experience, that is one thing. Pointing followers to a vendor while associating your content with therapeutic-sounding hashtags crosses into territory that regulators and platform safety teams are increasingly watching.

What should you actually know about these compounds?

Both Semax and SS-31 are research chemicals in the United States, not approved treatments. That does not mean the science is fake — it means the clinical pipeline is incomplete and the safety profile in healthy adults is poorly characterized.

Semax has a relatively benign reported side-effect profile in short-term studies, but long-term data in humans is essentially absent. SS-31's human trials have focused on specific disease populations, not healthy people using it for longevity optimization. Extrapolating from sick patients to healthy adults is a significant scientific jump that the peptide community routinely glosses over.

If you are considering either compound, that conversation belongs with a licensed clinician who can review your full health picture, not a TikTok vendor link. Compounded peptides from telehealth platforms operate under different regulatory frameworks than research-chemical vendors, and that distinction is not cosmetic — it affects potency verification, sterility testing, and medical oversight.